Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
0192623308320272v1
36/5/660    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Google Scholar
Right arrow Articles by Kwon, S.-B.
Right arrow Articles by Yoon, B.-I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwon, S.-B.
Right arrow Articles by Yoon, B.-I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
First published on July 22, 2008, doi:10.1177/0192623308320272

Toxicologic Pathology 2008;36:660.

A more recent version of this article appeared on July 1, 2008

Article

Time- and Dose-based Gene Expression Profiles Produced by a Bile-duct–damaging Chemical, 4,4-methylene Dianiline, in Mouse Liver in an Acute Phase

Sun-Bom Kwon, Joon-Suk Park, Jung-Yeon Yi, Jae-Wong Hwang, Mingoo Kim, Mi-Ock Lee, Byung-Hoon Lee, Hyung-Lae Kim, Ju Han Kim, HeeKyoung Chung, Gu Kong, Kyung-Sun Kang, and Byung-IL Yoon*

* To whom correspondence should be addressed. E-mail: byoon{at}kangwon.ac.kr.


  Abstract
A toxicogenomics study was performed in the mouse liver after treatment of a bile-duct–damaging chemical, 4,4’-methylene dianiline (MDA), across multiple doses and sampling times in an acute phase using the AB Expression Array System. Imprinting control region (ICR) mice were given a single oral administration of a low (10 mg/kg b.w.) or high (100 mg/kg b.w.) dose of MDA. Mice were sacrificed six, twenty-four, and seventy-two hours after treatment for serum chemistry, histopathology, and mRNA preparation from liver samples. Treatment with MDA increased liver-toxicity–related enzymes in blood and induced bile-duct cell injury, followed by regeneration. To explore potential biomarker gene profiles, the altered genes were categorized into four expression patterns depending on dose and time. Numerous functionally defined and unclassified genes in each category were up- or down-regulated throughout the period from cellular injury to the recovery phase, verified by RT-PCR. Many genes associated with liver toxicity and diseases belonged to one of these categories. The chemokine-mediated Th1 pathway was implicated in the inflammatory process. The genes associated with oxidative stress, apoptosis, and cell-cycle regulation were also dynamically responsive to MDA treatment. The Wnt/{beta}-catenin signaling pathway was likely responsible for the reconstitution process of the MDA-injured liver.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?